2.4.0.80020 - Disclosure - Subsequent Eventstruefalsefalse1falsefalsefalseFrom2013-01-01to2013-06-30http://www.sec.gov/CIK0001125699duration2013-01-01T00:00:002013-06-30T00:00:001true1DLYT_NotesToFinancialStatementsAbstractDLYT_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse02false2us-gaap_SubsequentEventsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 15, 2013, the Company issued, pursuant
to a Stock Purchase Agreement with one private investor (the “Investor”), 2,350,000 restricted shares of the Company’s
common stock at a purchase price of $0.10 per share for a total of $235,000. With the issuance of the common stock, the Company
issued warrants to purchase 587,500 shares of the Company’s common stock at $0.50 per share. The Warrants are exercisable
for 60 months. The warrants are subject to standard anti-dilution adjustments for stock splits and other subdivisions. The proceeds
from the sale of the securities shall be used for working capital purposes.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2013, the Company received $149,915
from an investor under another SPA entered into on May 31, 2013, towards the purchase of common stock at $0.10 per share. Subsequent
to June 30, 2013, the Company issued 1,499,150 in settlement of the common stock payable. With the issuance of the common stock,
the Company issued warrants to purchase 374,788 shares of the Company’s common stock at $0.50 per share. The warrants are
exercisable for 60 months. The warrants are subject to standard anti-dilution adjustments for stock splits and other subdivisions.
The proceeds from the sale of the securities shall be used for working capital purposes.</p>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.No definition available.false0falseSubsequent EventsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://daisanalytic.com/role/SubsequentEvents12